(Q35062803)

6 August 2017

1 reference

title

Better blood pressure control: how to combine drugs (English)

1 reference

6 August 2017

3

1 reference

6 August 2017

M J Brown

1

1 reference

6 August 2017

J K Cruickshank

2

1 reference

6 August 2017

G A MacGregor

4

1 reference

6 August 2017

N R Poulter

5

1 reference

6 August 2017

G I Russell

6

1 reference

6 August 2017

S Thom

7

1 reference

6 August 2017

B Williams

8

1 reference

6 August 2017

Executive Committee, British Hypertension Society

9

1 reference

6 August 2017

1 February 2003

1 reference

Journal of Human Hypertension

6 August 2017

1 reference

6 August 2017

17

1 reference

6 August 2017

81-86

1 reference

6 August 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.jhh.1001511

6 August 2017

0 references

cites work

Evidence-Based Health Policy---Lessons from the Global Burden of Disease Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001511

Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001511

Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001511

British Hypertension Society guidelines for hypertension management 1999: summary

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001511

Case-control study of stroke and the quality of hypertension control in north west England

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001511

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001511

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001511

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001511

Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001511

Antihypertensive beta blocking action as related to renin and age: A pharmacologic tool to identify pathogenetic mechanisms in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001511

Double-blind, placebo-controlled crossover comparison of five classes of antihypertensive drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001511

Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001511

Dissociation of plasma renin activity and aldosterone in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001511

Randomised, double blind, multicentre comparison of hydrochlorothiazide, atenolol, nitrendipine, and enalapril in antihypertensive treatment: results of the HANE study. HANE Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001511

The 'Birmingham Hypertension Square' for the optimum choice of add-in drugs in the management of resistant hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001511

Rationale, design, methods and baseline demography of participants of the Anglo-Scandinavian Cardiac Outcomes Trial. ASCOT investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001511

Hypertension awareness, treatment and control in the community: is the 'rule of halves' still valid?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001511

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001511

The renin angiotensin system and cardiovascular disease: hope or hype?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001511

Blood-pressure reduction and cardiovascular risk in HOPE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001511

Comparative effects of ramipril on ambulatory and office blood pressures: a HOPE Substudy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001511

Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001511

The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001511

7 January 2021

Improved hypertension management and control: results from the health survey for England 1998

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001511

7 January 2021

Blood pressure screening, management and control in England

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001511

7 January 2021

1999 World Health Organization-International Society of Hypertension Guidelines for the management of hypertension. Guidelines sub-committee of the World Health Organization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001511

7 January 2021

Optimisation of antihypertensive treatment by crossover rotation of four major classes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001511

7 January 2021

The St George's 'Star' and 'Imploding Diamond'

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001511

7 January 2021

Long-term metabolic effects of antihypertensive drugs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001511

7 January 2021

High incidence of primary aldosteronism in 199 patients referred with hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001511

7 January 2021

Potentially high prevalence of primary aldosteronism in a primary-care population

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001511

7 January 2021

Identifiers

DOI

10.1038/SJ.JHH.1001511

1 reference

6 August 2017

1 reference